Evidence map›Paper›PMID 31645541›Full record

ArticleNutrition & diabetes2019

The flavonoid-rich Quzhou Fructus Aurantii extract modulates gut microbiota and prevents obesity in high-fat diet-fed mice.

Yong-Feng Bai, Si-Wei Wang, Xiao-Xiao Wang, Yuan-Yuan Weng, Xue-Yu Fan, Hao Sheng, Xin-Tian Zhu, Li-Jun Lou, Feng Zhang

Open access · goldAbstract read
In one paragraph

Article in Nutrition & diabetes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 117 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Nutrients · 2025
    Article
  10. Article
  11. Article
  12. Dietary supplementation ofFrontiers in veterinary science · 2025
    Article
  13. Effects ofAnimals : an open access journal from MDPI · 2024
    Article
  14. Article
  15. Article
  16. Polysaccharides fromMicroorganisms · 2024
    Article
  17. Article
  18. Article
  19. Nutrients · 2024
    Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yong-Feng BaiDepartment of Clinical Laboratory, Quzhou People's Hospital, 324000, Quzhou, China.
Si-Wei WangDepartment of Core Facility, Quzhou People's Hospital, 324000, Quzhou, China.
Xiao-Xiao WangDepartment of Drug Analysis Center, Quzhou Institute for Food and Drug Control, 324000, Quzhou, China.
Yuan-Yuan WengDepartment of Clinical Laboratory, Quzhou People's Hospital, 324000, Quzhou, China.
Xue-Yu FanDepartment of Clinical Laboratory, Quzhou People's Hospital, 324000, Quzhou, China.
Hao ShengMedical School, Zhejiang University, 310058, Hangzhou, China.
Xin-Tian ZhuWenzhou Medical University, 325000, Wenzhou, China.
Li-Jun LouDepartment of Pharmacy, Quzhou People's Hospital, 324000, Quzhou, China. lljqz@aliyun.com.
Feng ZhangDepartment of Clinical Laboratory, Quzhou People's Hospital, 324000, Quzhou, China. felix.f.zhang@outlook.com.ORCID http://orcid.org/0000-0002-6751-0377
Quzhou City People's Hospital · CNZhejiang Chinese Medical University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFlavonoids are reported to modulate the composition of gut microbiota, which play an important role in preventing obesity and associated metabolic diseases. In this study, we investigated the effect of Total Flavonoids of Quzhou Fructus Aurantii Extract (TFQ) on gut microbial community in mice fed with a high-fat diet (HFD).

methodsC57BL/6J mice were fed with either a chow diet or HFD with or without oral gavage of TFQ (300 mg/kg/day) for 12 weeks.

resultsOur data indicate TFQ significantly reduced obesity, inflammatio,n and liver steatosis. TFQ elevates the expression of tight junction proteins and reduces metabolic endotoxemia. In addition, TFQ treatment reverses HFD-induced gut dysbiosis, as indicated by the reduction of Firmicutes to Bacteroidetes ratio, the increase of genera Akkermansia and Alistipes, and the decrease of genera Dubosiella, Faecalibaculum, and Lactobacillus.

conclusionThese findings support a prebiotic role of TFQ as a dietary supplement for the intervention of gut dysbiosis and obesity-related metabolic disorders.

Indexed as

Diet, High-FatAnimalsBlood GlucoseCholesterolDisease Models, AnimalFlavonoidsGastrointestinal MicrobiomeInsulin ResistanceMiceMice, Inbred C57BLObesityPlant ExtractsBlood GlucoseCholesterolFlavonoidsPlant Extracts

Identifiers

PMID31645541
PMCPMC6811639
OpenAlexW2981885402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.